Tags: anti-scar medication | Microcyn Scar Management HydroGel | burns | trauma wounds

FDA OKs New Treatment for Scars

Wednesday, 04 Dec 2013 12:45 PM


Oculus Innovative Sciences Inc's shares more than doubled after the U.S. Food and Drug Administration approved the company's anti-scar treatment for raised and red scars resulting from burns, surgical procedures and trauma wounds.
The treatment, Microcyn Scar Management HydroGel, will be marketed by Oculus's U.S. dermatology partner, Quinnova Pharmaceuticals, in the first half of 2014.
This is the eighth FDA approval for Microcyn-based products, Oculus CEO Jim Schutz said in a statement on Wednesday.
Oculus said it expected to market the product in Mexico next year with its Latin American partner, More Pharma.
The launch of the treatment in China, Singapore, Malaysia and India is expected after April, the Petaluma, California-based company said.
An estimated 62 million scars are formed each year in the United States, the company said, quoting a 2003 report by market research firm Frost & Sullivan.
 

© 2017 Thomson/Reuters. All rights reserved.

 
1Like our page
2Share
Health-News
Oculus Innovative Sciences Inc's shares more than doubled after the U.S. Food and Drug Administration approved the company's anti-scar treatment for raised and red scars resulting from burns, surgical procedures and trauma wounds. The treatment, Microcyn Scar Management...
anti-scar medication,Microcyn Scar Management HydroGel,burns,trauma wounds
140
2013-45-04
Wednesday, 04 Dec 2013 12:45 PM
Newsmax Inc.
 

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved